tiprankstipranks
Trending News
More News >
Oragenics Inc (OGEN)
:OGEN
US Market

Oragenics (OGEN) Income Statement

Compare
1,063 Followers

Oragenics Income Statement

Last quarter (Q4 2025), Oragenics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Oragenics's net income was $-2.29M. See Oragenics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 9.36M$ 10.56M$ 20.90M$ 14.42M$ 15.77M
Depreciation and Amortization
$ 0.00$ 0.00$ 27.39K$ 44.67K$ 41.24K
EBITDA
$ -9.36M$ -10.54M$ -20.60M$ -14.23M$ -15.65M
Operating Income
$ -9.36M$ -10.56M$ -20.90M$ -14.42M$ -15.77M
Other Income/Expenses
$ -616.89K$ -9.10K$ 249.17K$ 132.38K$ 59.40K
Pretax Income
$ -9.98M$ -10.57M$ -20.66M$ -14.29M$ -15.71M
Net Income
$ -9.84B$ -10.57M$ -20.66M$ -14.29M$ -15.71M
Per Share Metrics
Basic EPS
$ -4.56$ -1.60$ -9.18$ -7.11$ -8.09
Diluted EPS
$ -4.56$ -1.60$ -9.18$ -7.11$ -8.09
Weighted Average Shares Outstanding
2.16M 6.62M 2.25M 2.01M 1.88M
Weighted Average Shares Outstanding (Diluted)
2.16M 6.62M 2.25M 2.01M 1.88M
Currency in USD

Oragenics Earnings and Revenue History